For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.

Functional domains of the yeast splicing factor Prp22p.

TitleFunctional domains of the yeast splicing factor Prp22p.
Publication TypeJournal Article
Year of Publication2001
AuthorsSchneider S, Schwer B
JournalJ Biol Chem
Volume276
Issue24
Pagination21184-91
Date Published2001 Jun 15
ISSN0021-9258
KeywordsAdenosine Triphosphatases, Amino Acid Sequence, Base Sequence, Conserved Sequence, DEAD-box RNA Helicases, Fungal Proteins, Kinetics, Molecular Sequence Data, Mutagenesis, Site-Directed, Polyribonucleotides, Recombinant Proteins, RNA Helicases, RNA Splicing, RNA, Messenger, Saccharomyces cerevisiae, Saccharomyces cerevisiae Proteins, Sequence Alignment, Sequence Homology, Amino Acid, Spliceosomes, Substrate Specificity
Abstract

The essential Saccharomyces cerevisiae PRP22 gene encodes a 1145-amino acid DEXH box RNA helicase. Prp22p plays two roles during pre-mRNA splicing as follows: it is required for the second transesterification step and for the release of mature mRNA from the spliceosome. Whereas the step 2 function of Prp22p does not require ATP hydrolysis, spliceosome disassembly is dependent on the ATPase and helicase activities. Here we delineate a minimal functional domain, Prp22(262-1145), that suffices for the activity of Prp22p in vivo when expressed under the natural PRP22 promoter and for pre-mRNA splicing activity in vitro. The biologically active domain lacks an S1 motif (residues 177-256) that had been proposed to play a role in RNA binding by Prp22p. The deletion mutant Prp22(351-1145) can function in vivo when provided at a high gene dosage. We suggest that the segment from residues 262 to 350 enhances Prp22p function in vivo, presumably by targeting Prp22p to the spliceosome. We characterize an even smaller catalytic domain, Prp22(466-1145) that suffices for ATP hydrolysis, RNA binding, and RNA unwinding in vitro and for nuclear localization in vivo but cannot by itself support cell growth. However, the ATPase/helicase domain can function in vivo if the N-terminal region Prp22(1-480) is co-expressed in trans.

DOI10.1074/jbc.M101964200
Alternate JournalJ. Biol. Chem.
PubMed ID11283007
Grant ListGM50288 / GM / NIGMS NIH HHS / United States

Weill Cornell Medicine Microbiology and Immunology 1300 York Avenue, Box 62 New York, NY 10065 Phone: (212) 746-6505 Fax: (212) 746-8587